TREAT-COVID: Calling on Organ and Stem Cell Transplant Patients, Families, and Caregivers to Enroll
Most COVID-19 studies do not include the transplant community. Without studies, government policies and recommendations will not include the transplant community. A new study led by The CDTRP examines how COVID-19 and other respiratory viruses continue to affect child and adult transplant recipients and their family members and caregivers living in Canada.
By participating in this study, transplant recipients and their families will help improve transplant care. The study is called Addressing Critical Issues and Therapeutics Emerging in Transplantation in COVID-19 for Transplant Recipients (TREAT-COVID).
  • Adult or child transplant recipients and one of their family members or caregivers are welcome to participate.
  • Participants complete online or paper questionnaires.
  • The study will last for approximately two years.
  • Participants will receive an honorarium gift card valued at $15 for participating in this study.
We are currently recruiting from 10 out of the 11 sites, see details below: 
  •  Alberta – University of Alberta, Stollery Children’s Hospital 
  • Québec – Centre Hospitalier Universitaire de Quebec (CHUQ), Centre Hospitalier Universitaire de Montréal (CHUM), Montreal Children’s Hospital and Institut de Cardiologie de Montréal (ICM)
  • Ontario – London Health Sciences Center, UHN
  • British Columbia – BC Children’s Hospital, Vancouver General Hospital 
Recruitment from the final site will begin soon.
To participate, learn more or join an email list to receive updates, visit THIS LINK or email info@cdtrp.ca.